Ross JS - Search Results

1

US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019.

Dhodapkar MM, Ross JS, Ramachandran R. Dhodapkar MM, et al. Among authors: ross js. JAMA Netw Open. 2023 Jun 1;6(6):e2318889. doi: 10.1001/jamanetworkopen.2023.18889. JAMA Netw Open. 2023. PMID: 37358857 Free PMC article.

2

Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study.

Mooghali M, Glick L, Ramachandran R, Ross JS. Mooghali M, et al. Among authors: ross js. BMJ Open. 2023 Jan 23;13(1):e069115. doi: 10.1136/bmjopen-2022-069115. BMJ Open. 2023. PMID: 36690402 Free PMC article.

3

Extending the US Food and Drug Administration's Postmarket Authorities.

Fernandez Lynch H, Sachs RE, Lee S, Herder M, Ross JS, Ramachandran R. Fernandez Lynch H, et al. Among authors: ross js. JAMA Health Forum. 2023 Jun 2;4(6):e231313. doi: 10.1001/jamahealthforum.2023.1313. JAMA Health Forum. 2023. PMID: 37294583 Free article.

4

Use of Expedited Regulatory Programs and Clinical Development Times for FDA-Approved Novel Therapeutics.

Wong AK, Mooghali M, Ramachandran R, Ross JS, Wallach JD. Wong AK, et al. Among authors: ross js. JAMA Netw Open. 2023 Aug 1;6(8):e2331753. doi: 10.1001/jamanetworkopen.2023.31753. JAMA Netw Open. 2023. PMID: 37651145 Free PMC article.

5

Pivotal Trial Demographic Representation and Clinical Development Times for Oncology Therapeutics.

Wong AK, Miller JE, Mooghali M, Ramachandran R, Ross JS, Wallach JD. Wong AK, et al. Among authors: ross js. JAMA. 2023 Dec 26;330(24):2392-2394. doi: 10.1001/jama.2023.21958. JAMA. 2023. PMID: 38079163 Free PMC article.

6

Innovation in Development of Dermatologic Drugs Approved by the US Food and Drug Administration Between 2012 and 2022.

Kamat S, Ungar B, Agarwal A, Wan J, Ross JS, Gupta R. Kamat S, et al. Among authors: ross js. JAMA Dermatol. 2024 Feb 1;160(2):226-229. doi: 10.1001/jamadermatol.2023.5036. JAMA Dermatol. 2024. PMID: 38117528

7

Association of health benefits and harms of Christmas dessert ingredients in recipes from The Great British Bake Off: umbrella review of umbrella reviews of meta-analyses of observational studies.

Wallach JD, Gautam A, Ramachandran R, Ross JS. Wallach JD, et al. Among authors: ross js. BMJ. 2023 Dec 20;383:e077166. doi: 10.1136/bmj-2023-077166. BMJ. 2023. PMID: 38123175 Free article.

8

US FDA breakthrough therapy designation and consumer drug advertising: a recipe for confusion.

Patel NG, Mohammad A, Ross JS, Ramachandran R. Patel NG, et al. Among authors: ross js. BMJ. 2024 Feb 21;384:e076138. doi: 10.1136/bmj-2023-076138. BMJ. 2024. PMID: 38383007 No abstract available.

9

Implications for Public Health Regulation if Chevron Deference Is Overturned.

Agrawal S, Ross JS, Ramachandran R. Agrawal S, et al. Among authors: ross js. JAMA. 2024 May 7;331(17):1443-1444. doi: 10.1001/jama.2024.3654. JAMA. 2024. PMID: 38506706

10

Associations Between Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease Treatments.

Wallach JD, Yoon S, Doernberg H, Glick LR, Ciani O, Taylor RS, Mooghali M, Ramachandran R, Ross JS. Wallach JD, et al. Among authors: ross js. JAMA. 2024 May 21;331(19):1646-1654. doi: 10.1001/jama.2024.4175. JAMA. 2024. PMID: 38648042 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,700 results

Search Page

Filters